Proteomic profiling of pathological and aged skeletal muscle fibres by peptide mass fingerprinting (Review)

International Journal of Molecular Medicine

Volumn 19, Issue 4, 2007, Pages 547-564

  Doran, Philip ^a   Donoghue, Pamela ^a   O'Connell, Kathleen ^a   Gannon, Joan ^a   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Biomarker; Mass spectrometry; Muscular dystrophy; Peptide mass fingerprinting; Proteomics; Skeletal muscle aging

Indexed keywords

BIOLOGICAL MARKER; MUSCLE PROTEIN;

AGING; ANIMAL; CHEMISTRY; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; PEPTIDE MAPPING; PROTEOMICS; RAT; REVIEW; SKELETAL MUSCLE;

AGING; ANIMALS; BIOLOGICAL MARKERS; HUMANS; MICE; MUSCLE FIBERS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; PEPTIDE MAPPING; PROTEOMICS; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34247881871     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.4.547     Document Type: Review

References (142)

1. Mann M, Hendrickson RC and Pandey A: Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 70: 437-473, 2001. (Pubitemid 32662217)
2. Ferguson PL and Smith RD: Proteome analysis by mass spectrometry. Annu Rev Biophys Biomol Struct 32: 399-424, 2003.
3. Aebersold R and Mann M: Mass spectrometry-based proteomics. Nature 422: 198-207, 2003.
4. Lin D, Tabb DL and Yates JR III: Large-scale protein identification using mass spectrometry. Biochim Biophys Acta 1646: 1-10, 2003.
5. de Hoog CL and Mann M: Proteomics. Annu Rev Genomics Hum Genet 5: 267-293, 2004.
6. Yan W and Chen SS: Mass spectrometry-based quantitative proteomic profiling. Brief Funct Genomic Proteomic 4: 27-38, 2005. (Pubitemid 40724165)
7. Ong SE and Mann M: Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 1: 252-262, 2005.
8. Guerrera IC and Kleiner O: Application of mass spectrometry in proteomics. Biosci Rep 25: 71-93, 2005.
9. Domon B and Aebersold R: Mass spectrometry and protein analysis. Science 312: 212-217, 2006.
10. Gorg A, Weiss W and Dunn MJ: Current two-dimensional electrophoresis technology for proteomics. Proteomics 4: 3665-3685, 2004.
11. Wu CC and Yates JR III: The application of mass spectrometry to membrane proteomics. Nat Biotechnol 21: 262-267, 2003. (Pubitemid 36314809)
12. Mann M and Jensen ON: Proteomic analysis of post-translational modifications. Nat Biotechnol 21: 255-261, 2003.
13. Seo J and Lee KJ: Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J Biochem Mol Biol 37: 35-44, 2004. (Pubitemid 38402572)
14. Jensen ON: Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry. Curr Opin Chem Biol 8: 33-41, 2004. (Pubitemid 38201475)
15. van den Heuvel LP, Farhoud MH, Wevers RA, van Engelen BG and Smeitink JA: Proteomics and neuromuscular diseases: theoretical concept and first results. Ann Clin Biochem 40: 9-15, 2003.
16. Cobon GS, Verrills N, Papakostopoulos P, Eastwood H and Linnane AW: The proteomics of ageing. Biogerontology 3: 133-136, 2002.
17. Engel AG and Franzini-Armstrong C: The scientific basis of myology. In: Basic and Clinical Myology. Vol. 1, McGraw-Hill Inc., New York, pp1-735, 1994.
18. Pette D: Historical perspectives: plasticity of mammalian skeletal muscle. J Appl Physiol 90: 1119-1124, 2001.
19. Pette D: The adaptive potential of skeletal muscle fibers. Can J Appl Physiol 27: 423-448, 2002.
20. Fluck M and Hoppeler H: Molecular basis of skeletal muscle plasticity - from gene to form and function. Rev Physiol Biochem Pharmacol 146: 159-216, 2003.
21. Lu DX, Huang SK and Carlson BM: Electron microscopic study of long-term denervated rat skeletal muscle. Anat Rec 248: 355-365, 1997. (Pubitemid 27280142)
22. Pette D and Staron RS: Transitions of muscle fiber phenotypic profiles. Histochem Cell Biol 115: 359-372, 2001. (Pubitemid 32467749)
23. Carlson BM, Billington L and Faulkner JA: Studies on the regenerative recovery of long-term denervated muscle in rats. Restor Neurol Neurosci 10: 77-84, 1996. (Pubitemid 26329429)
24. Goldspink G: Gene expression in muscle in response to exercise. J Muscle Res Cell Motil 24: 121-126, 2003. (Pubitemid 37323615)
25. Ohira Y, Yoshinaga T, Nomura T, Kawano F, Ishihara A, Nonaka I, Roy RR and Edgerton VR: Gravitational unloading effects on muscle fiber size, phenotype and myonuclear number. Adv Space Res 30: 777-781, 2002.
26. Isfort RJ: Proteomic analysis of striated muscle. J Chromatogr B 771: 155-165, 2002.
27. Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VA, Pertz LM, Haugen E, Hayden H, Albertson D, Pinkel D, Olson MV and Eichler EE: Fine-scale structural variation of the human genome. Nat Genet 37: 727-732, 2005.
28. LeBihan MC, Tarelli E and Coulton GR: Evaluation of an integrated strategy for proteomic profiling of skeletal muscle. Proteomics 4: 2739-2753, 2004.
29. Towbin H, Staehelin T and Gordon J: Immunoblotting in the clinical laboratory. J Clin Chem Clin Biochem 27: 495-501, 1989.
30. Bienvenut WV, Deon C, Pasquarello C, Campbell JM, Sanchez JC, Vestal ML and Hochstrasser DF: Matrix-assisted laser desorption/ionization-tandem mass spectrometry with high resolution and sensitivity for identification and characterization of proteins. Proteomics 2: 868-876, 2002.
31. Webster J and Oxley D: Peptide mass fingerprinting: protein identification using MALDI-TOF mass spectrometry. Methods Mol Biol 310: 227-240, 2005.
32. Celis JE, Honore B, Bauw G and Vandekerckhove J: Comprehensive computerized 2D gel protein databases offer a global approach to the study of the mammalian cell. Bioessays 12: 93-97, 1990.
33. Sanchez JC, Chiappe D, Converset V, Hoogland C, Binz PA, Paesano S, Appel RD, Wang S, Sennitt M, Nolan A, Cawthorne MA and Hochstrasser DF: The mouse SWISS-2DPAGE database: a tool for proteomic study of diabetes and obesity. Proteomics 1: 136-163, 2001.
34. Doran P, Dowling P, Donoghue P, Buffini M and Ohlendieck K: Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochim Biophys Acta 1764: 773-785, 2006.
35. Doran P, Martin G, Dowling P, Jockusch H and Ohlendieck K: Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 6: 4610-4621, 2006.
36. Henzel WJ, Bourell JH and Stults JT: Analysis of protein digests by capillary high-performance liquid chromatography and on-line fast atom bombardment mass spectrometry. Anal Biochem 187: 228-233, 1990.
37. Henzel WJ, Watanabe C and Stults JT: Protein identification: the origins of peptide mass fingerprinting. J Am Soc Mass Spectrom 14: 931-942, 2003.
38. Burlingame AL, Carr SA and Baldwin MA: Mass Spectrometry in Biology and Medicine. Humana Press, Totowa, NJ, pp1-577, 2000.
39. Pennington SR and Dunn MJ: Proteomics: From Protein Sequence to Function. Springer Verlag, New York, pp1-313, 2001.
40. Westermeier R and Naven T: Proteomics in Practice. Wiley-VCH Verlag, Weinheim, pp1-318, 2002.
41. Walker JM: Proteomics Protocols Handbook. Humana Press, Tototowa, NJ, pp1-988, 2005.
42. Jarrold B, DeMuth J, Greis K, Burt T and Wang F: An effective skeletal muscle prefractionation method to remove abundant structural proteins for optimized two-dimensional gel electrophoresis. Electrophoresis 26: 2269-2278, 2005.
43. Engel AG and Franzini-Armstrong C: The scientific basis of myology. In: Basic and Clinical Myology. Vol. 2, McGraw-Hill Inc., New York, pp1130-1937, 1994.
44. Melton LJ III, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM and Riggs BL: Epidemiology of sarcopenia. J Am Geriatr Soc 48: 625-630, 2000.
45. Morley JE, Baumgartner RN, Roubenoff R, Mayer J and Nair KS: Sarcopenia. J Lab Clin Med 137: 231-243, 2001.
46. Greenlund LJS and Nair KS: Sarcopenia - consequences, mechanisms, and potential therapies. Mech Ageing Dev 124: 287-299, 2003.
47. Froemming GR and Ohlendieck K: The role of ion-regulatory membrane proteins of excitation-contraction coupling and relaxation in inherited muscle diseases. Front Biosci 6: D65-D74, 2001.
48. 2+-regulatory membrane proteins in normal, stimulated and pathological skeletal muscle fibres (Review). Int J Mol Med 1: 677-697, 1998.
49. Ohlendieck K: Malignant hyperthermia: a pharmacogenetic disease of excitation-contraction coupling. Curr Trends Neurol 1: 101-108, 2005.
50. Unlu M, Morgan ME and Minden JS: Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18: 2071-2077, 1997. (Pubitemid 27501267)
51. Unlu M: Difference gel electrophoresis. Biochem Soc Trans 27: 547-549, 1999.
52. Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, Pognan F, Hawkins E, Currie I and Davison M: Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1: 377-396, 2001.
53. Marouga R, David S and Hawkins E: The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382: 669-678, 2005. (Pubitemid 40890994)
54. Donoghue P, Doran P, Dowling P and Ohlendieck K: Differential expression of the fast skeletal muscle proteome following chronic low-frequency stimulation. Biochim Biophys Acta 1752: 166-176, 2005.
55. Pette D and Staron RS: Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol 116: 1-76, 1990.
56. 2+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. Eur J Biochem 271: 3943-3952, 2004.
57. Froemming GR and Ohlendieck K: Native skeletal muscle dihydropyridine receptor exists as a supramolecular triad complex. Cell Mol Life Sci 58: 312-320, 2001.
58. Culligan KG, Mackey AJ, Finn DM, Maguire PB and Ohlendieck K: Role of dystrophin isoforms and associated proteins in muscular dystrophy (Review). Int J Mol Med 2: 639-648, 1998.
59. Froemming GR, Murray BE and Ohlendieck K: Self-aggregation of triadin in the sarcoplasmic reticulum of rabbit skeletal muscle. Biochim Biophys Acta 1418: 197-205, 1990.
60. Yan JX, Harry RA, Wait R, Welson SY, Emery PW, Preedy V and Dunn MJ: Separation and identification of rat skeletal muscle proteins using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 1: 424-434, 2001.
61. Bouley J, Chambon C and Picard B: Mapping of bovine skeletal muscle proteins using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4: 1811-1824, 2004.
62. Chaze T, Bouley J, Chambon C, Barboiron C and Picard B: Mapping of alkaline proteins in bovine skeletal muscle. Proteomics 6: 2571-2575, 2006.
63. Gelfi C, De Palma S, Cerretelli P, Begum S and Wait R: Two-dimensional protein map of human vastus lateralis muscle. Electrophoresis 24: 286-295, 2003.
64. Capitanio D, Vigano A, Ricci E, Cerretelli P, Wait R and Gelfi C: Comparison of protein expression in human deltoideus and vastus lateralis muscles using two-dimensional gel electrophoresis. Proteomics 5: 2577-2586, 2005.
65. Li ZB, Lehar M, Braga N, Westra W, Liu LH and Flint PW: Study of human laryngeal muscle protein using two-dimensional electrophoresis and mass spectrometry. Proteomics 3: 1325-1334, 2003. (Pubitemid 36929555)
66. Kim NK, Joh JH, Park HR, Kim OH, Park BY and Lee CS: Differential expression profiling of the proteomes and their mRNAs in porcine white and red skeletal muscles. Proteomics 4: 3422-3428, 2004.
67. Le Bihan MC, Hou Y, Harris N, Tarelli E and Coulton GR: Proteomic analysis of fast and slow muscles from normal and kyphoscoliotic mice using protein arrays, 2-DE and MS. Proteomics 6: 4646-4661, 2006. (Pubitemid 44336978)
68. Okumura N, Hashida-Okumura A, Kita K, Matsubae M, Matsubara T, Takao T and Nagai K: Proteomic analysis of slow- and fast-twitch skeletal muscles. Proteomics 5: 2896-2906, 2006. (Pubitemid 41059767)
69. Gelfi C, Vigano A, De Palma S, Ripamonti M, Begum S, Cerretelli P and Wait R: 2-D protein maps of rat gastrocnemius and soleus muscles: a tool for muscle plasticity assessment. Proteomics 6: 321-340, 2006.
70. Forner F, Foster LJ, Campanaro S, Valle G and Mann M: Quantitative proteomic comparison of rat mitochondria from muscle, heart, and liver. Mol Cell Proteomics 5: 608-619, 2006.
71. Cieniewski-Bernard C, Bastide B, Lefebvre T, Lemoine J, Mounier Y and Michalski JC: Identification of O-linked N-acetylglucosamine proteins in rat skeletal muscle using two-dimensional gel electrophoresis and mass spectrometry. Mol Cell Proteomics 3: 577-585, 2004. (Pubitemid 38878517)
72. Doherty MK, McLean L, Hayter JR, Pratt JM, Robertson DH, El-Shafei A, Gaskell SJ and Beynon RJ: The proteome of chicken skeletal muscle: changes in soluble protein expression during growth in a layer strain. Proteomics 4: 2082-2093, 2004. (Pubitemid 38880373)
73. Kislinger T, Gramolini AO, Pan Y, Rahman K, MacLennan DH and Emili A: Proteome dynamics during C2C12 myoblast differentiation. Mol Cell Proteomics 4: 887-901, 2005. (Pubitemid 41309147)
74. Takahashi M and Kubota S: Exercise-related novel gene is involved in myoblast differentiation. Biomed Res 26: 79-85, 2005. (Pubitemid 41519992)
75. Bouley J, Meunier B, Chambon C, De Smet S, Hocquette JF and Picard B: Proteomic analysis of bovine skeletal muscle hypertrophy. Proteomics 5: 490-500, 2005. (Pubitemid 40262066)
76. Kjaersgard IV, Norrelykke MR and Jessen F: Changes in cod muscle proteins during frozen storage revealed by proteome analysis and multivariate data analysis. Proteomics 6: 1606-1618, 2006.
77. Martin SA, Vilhelmsson O, Medale F, Watt P, Kaushik S and Houlihan DF: Proteomic sensitivity to dietary manipulations in rainbow trout. Biochim Biophys Acta 1651: 17-29, 2003.
78. Gajendran N, Frey JR, Lefkovits I, Kuhn L, Fountoulakis M, Krapfenbauer K and Brenner HR: Proteomic analysis of secreted muscle components: search for factors involved in neuromuscular synapse formation. Proteomics 2: 1601-1615, 2002.
79. Isfort RJ, Wang F, Greis KD, Sun Y, Keough TW, Farrar RP, Bodine SC and Anderson NL: Proteomic analysis of rat soleus muscle undergoing hindlimb suspension-induced atrophy and reweighting hypertrophy. Proteomics 2: 543-550, 2002.
80. Isfort RJ, Wang F, Greis KD, Sun Y, Keough TW, Bodine SC and Anderson NL: Proteomic analysis of rat soleus and tibialis anterior muscle following immobilization. J Chromatogr B Anal Technol Biomed Life Sci 769: 323-332, 2002.
81. Ge Y, Molloy MP, Chamberlain JS and Andrews PC: Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 3: 1895-1903, 2003.
82. Ge Y, Molloy MP, Chamberlain JS and Andrews PC: Differential expression of the skeletal muscle proteome in mdx mice at different ages. Electrophoresis 25: 2576-2585, 2004. (Pubitemid 39193668)
83. De Palma S, Morandi L, Mariani E, Begum S, Cerretelli P, Wait R and Gelfi C: Proteomic investigation of the molecular pathophysiology of dysferlinopathy. Proteomics 6: 379-385, 2006.
84. Kanski J, Alterman MA and Schoneich C: Proteomic identification of age-dependent protein nitration in rat skeletal muscle. Free Radic Biol Med 35: 1229-1239, 2003. (Pubitemid 37357248)
85. Kanski J, Hong SJ and Schoneich C: Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine- containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry. J Biol Chem 280: 24261-24266, 2005.
86. Chang J, Van Remmen H, Cornell J, Richardson A and Ward WF: Comparative proteomics: characterization of a two-dimensional gel electrophoresis system to study the effect of aging on mitochondrial proteins. Mech Ageing Dev 124: 33-41, 2003.
87. Piec I, Listrat A, Alliot J, Chambon C, Taylor RG and Bechet D: Differential proteome analysis of aging in rat skeletal muscle. FASEB J 19: 1143-1145, 2005. (Pubitemid 40946445)
88. Gelfi C, Vigano A, Ripamonti M, Pontoglio A, Begum S, Pellegrino MA, Grassi B, Bottinelli R, Wait R and Cerretelli P: The human muscle proteome in aging. J Proteome Res 5: 1344-1353, 2006.
89. Emery AE: The muscular dystrophies. Lancet 359: 687-695, 2002.
90. Ahn AH and Kunkel LM: The structural and functional diversity of dystrophin. Nat Genet 3: 283-291, 1993.
91. Cohn RD and Campbell KP: Molecular basis of muscular dystrophies. Muscle Nerve 23: 1456-1471, 2000.
92. Rando TA: Role of nitric oxide in the pathogenesis of muscular dystrophies: a 'two hit' hypothesis of the cause of muscle necrosis. Microsc Res Tech 55: 223-235, 2001.
93. Ohlendieck K: Towards an understanding of the dystrophinglycoprotein complex: linkage between the extracellular matrix and the subsarcolemmal membrane cytoskeleton. Eur J Cell Biol 69: 1-10, 1996.
94. Alderton JM and Steinhardt RA: Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J Biol Chem 275: 9452-9460, 2000.
95. Alderton JM and Steinhardt RA: How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc Med 10: 268-272, 2000.
96. Ohlendieck K: The pathophysiological role of impaired calcium handling in muscular dystrophy. In: Molecular Mechanisms of Muscular Dystrophies. Winder SJ (ed). Landes Bioscience, Georgetown, TX, pp183-192, 2006.
97. Batchelor CL and Winder SJ: Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy. Trends Cell Biol 16: 198-205, 2006.
98. Winder SJ: Molecular Mechanisms of Muscular Dystrophies. Landes Bioscience, Georgetown, TX, pp1-233, 2006.
99. Dowling P, Doran P, Lohan J, Culligan K and Ohlendieck K: Naturally protected muscle phenotypes: Development of novel treatment strategies for Duchenne muscular dystrophy. Basic Appl Myol 14: 169-178, 2004.
100. Watchko JF, O'Day TL and Hoffman EP: Functional characteristics of dystrophic skeletal muscle: insights from animal models. J Appl Physiol 93: 407-417, 2002.
101. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri, RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT and Kelly AM: The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352: 536-539, 1991.
102. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG and Barnard PJ: The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578-1580, 1989.
103. Ohlendieck K and Campbell KP: Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115: 1685-1694, 1991.
104. Bulfield G, Silver WG, Wight PAL and Moore KJ: X-chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189-1192, 1984. (Pubitemid 14171480)
105. Torres LFB and Duchen LW: The mutant mdx: inherited myopathy in the mouse. Brain 110: 269-299, 1987.
106. Menke A and Jockusch H: Decreased osmotic stability of dystrophin-less muscle cells from mdx mouse. Nature 349: 69-71, 1991.
107. Lynch GS, Rafael JA, Chamberlain JS and Faulkner JA: Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice. Am J Physiol Cell Physiol 279: C1290-C1294, 2000.
108. DeLuca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Simonetti S, Papadia F and Camerino DC: Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine. Br J Pharmacol 132: 1047-1054, 2001.
109. Culligan K, Banville N, Dowling P and Ohlendieck K: Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. J Appl Physiol 92: 435-445, 2002.
110. Dowling P, Doran P and Ohlendieck K: Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. Biochem J 379: 479-488, 2004.
111. Nishimura RN and Sharp FR: Heat shock proteins and neuromuscular disease. Muscle Nerve 32: 693-709, 2005.
112. Bornman L, Polla BS, Lotz BP and Gericke GS: Expression of heat-shock/stress proteins in Duchenne muscular dystrophy. Muscle Nerve 18: 23-31, 1995.
113. Bouchentouf M, Benabdallah BF and Tremblay JP: Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 77: 1349-1356, 2004.
114. Kirkwood TB and Austad SN: Why do we age? Nature 408: 233-238, 2000.
115. Evans WJ: What is sarcopenia? J Gerontol 50A: 5-8, 1995.
116. Navarro A, Lopez-Cepero JM and Sanchez del Pino MJ: Skeletal muscle ageing. Front Biosci 6: 26-44, 2001.
117. Carmeli E, Coleman R and Reznick AZ: The biochemistry of aging muscle. Exp Gerontol 37: 477-489, 2002.
118. Toda T: Current status and perspectives of proteomics in aging research. Exp Gerontol 35: 803-810, 2000.
119. Martin GM: Some new directions for research on the biology of aging. Ann NY Acad Sci 908: 1-13, 2000.
120. Toda T: Proteome and proteomics for the research on protein alterations in aging. Ann NY Acad Sci 928: 71-78, 2001.
121. Schoneich C: Proteomics in gerontological research. Exp Gerontol 38: 473-481, 2003.
122. Larsson L and Ansved T: Effects of ageing on the motor unit. Prog Neurobiol 45: 397-458, 1995.
123. Luff AR: Age-associated changes in the innervation of muscle fibres and changes in the mechanical properties of motor units. Ann NY Acad Sci 854: 92-101, 1998.
124. Larsson L: The age-related motor disability: underlying mechanisms in skeletal muscle at the motor unit, cellular and molecular level. Acta Physiol Scand 163: S27-S29, 1998.
125. Carlson BM: Denervation and the aging of skeletal muscle. Basic Appl Myol 14: 135-140, 2004.
126. Skorjanc D, Traub I and Pette D: Identical responses of fast muscle to sustained activity by low-frequency-stimulation in young and aging rats. J Appl Physiol 85: 437-441, 1998. (Pubitemid 28365808)
127. Pette D and Skorjanc D: Adaptive potentials of skeletal muscle in young and aging rats. Int J Sport Nutr Exerc Metab 11: S3-S8, 2001.
128. Squier TS and Bigelow DJ: Protein oxidation and age-dependent alterations in calcium homeostasis. Front Biosci 5: 504-526, 2000.
129. Bua EA, McKiernan SH, Wanagat J, McKenzie D and Aiken JM: Mitochondrial abnormalities are more frequent in muscles undergoing sarcopenia. J Appl Physiol 92: 2617-2624, 2002.
130. Dirks A and Leeuwenburgh C: Apoptosis in skeletal muscle with aging. Am J Physiol 282: R519-R527, 2002.
131. Vandervoort AA and Symons TB: Functional and metabolic consequences of sarcopenia. Can J Appl Physiol 26: 90-101, 2001.
132. Roberts SB: Effects of aging on energy requirements and the control of food intake in men. J Gerontol 50A: 101-106, 1995.
133. Degens H: Age-related changes in the microcirculation of skeletal muscle. Adv Exp Med Biol 454: 343-348, 1998. (Pubitemid 29005547)
134. Balagopal P, Rooyackers OE, Adey DB, Ades PA and Nair KS: Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am J Physiol 273: E790-E800, 1997.
135. Ryan M and Ohlendieck K: Excitation-contraction uncoupling and sarcopenia. Basic Appl Myol 14: 141-154, 2004.
136. Renault V, Thornell LE, Eriksson PO, Butler-Browne G and Mouly V: Regenerative potential of human skeletal muscle during aging. Aging Cell 1: 132-139, 2002.
137. 2+-ATPase in skeletal muscle. Biochem J 340: 657-669, 1999.
138. Hicks A, Ohlendieck K, Gopel SO and Pette D: Early functional and biochemical adaptations to low-frequency stimulation of rabbit fast-twitch muscle. Am J Physiol 273: C297-C305, 1997.
139. 2+-regulatory membrane proteins during the stimulation-induced fast-to-slow transition process. Basic Appl Myol 10: 99-106, 2000.
140. 2+- regulatory membrane proteins in rabbit fast muscle. Pflugers Arch 438: 700-708, 1999.
141. 2+-regulatory membrane proteins in fast-twitch, slow-twitch, cardiac, neonatal and chronic low-frequency stimulated muscle fibers. Biochim Biophys Acta 1466: 151-168, 2000.
142. Emery AE: Muscular dystrophy into the new millennium. Neuromusc Disord 12: 343-349, 2002.